The history of the peat manufacturing industry in The Netherlands: Peat moss litter and active carbon by M.A.W. Gerding, E.H.K. Karel, G.E. de Vries

Get full text

Towards evidence-based response criteria for cancer immunotherapy by Elena Garralda, Scott A. Laurie, Lesley Seymour, Elisabeth G. E. de Vries

Get full text

Knowledge and use of biosimilars in oncology: a survey by the European Society for Medical Oncology by Josep Tabernero, Rosa Giuliani, Fatima Cardoso, Keith Hanson McGregor, Elisabeth G E de Vries

Get full text

Regulators of Homologous Recombination Repair as Novel Targets for Cancer Treatment by Małgorzata ekrajewska, Rudolf S.N. Fehrmann, Elisabeth G.E. de Vries, Marcel A.T.M. Van Vugt

Get full text

Growth differentiation factor 15 (GDF-15) plasma levels increase during bleomycin- and cisplatin-based treatment of testicular cancer patients and relate to endothelial damage. by Renske Altena, Rudolf S N Fehrmann, Hink Boer, Elisabeth G E de Vries, Coby Meijer, Jourik A Gietema

Get full text

89Zr-PET imaging to predict tumor uptake of 177Lu-NNV003 anti-CD37 radioimmunotherapy in mouse models of B cell lymphoma by Danique Giesen, Marjolijn N. Lub-de Hooge, Marcel Nijland, Helen Heyerdahl, Jostein Dahle, Elisabeth G. E. de Vries, Martin Pool

Get full text

Application of the ESMO-Magnitude of Clinical Benefit Scale (V.1.1) to the field of early breast cancer therapies by Fatima Cardoso, Elisabeth G E de Vries, Nathan I Cherny, Urania Dafni, Nicola Jane Latino, Shani Paluch-Shimon, Martine J Piccart

Get full text

Mitigation of noise-induced bias of PET radiomic features. by Ananthi Somasundaram, David Vállez García, Elisabeth Pfaehler, Joyce van Sluis, Rudi A J O Dierckx, Elisabeth G E de Vries, Ronald Boellaard

Get full text

Transcriptional effects of copy number alterations in a large set of human cancers by Arkajyoti Bhattacharya, Rico D. Bense, Carlos G. Urzúa-Traslaviña, Elisabeth G. E. de Vries, Marcel A. T. M. van Vugt, Rudolf S. N. Fehrmann

Get full text

Translating pharmacogenomics: challenges on the road to the clinic. by Jesse J Swen, Tom W Huizinga, Hans Gelderblom, Elisabeth G E de Vries, Willem J J Assendelft, Julia Kirchheiner, Henk-Jan Guchelaar

Get full text

Improving gene function predictions using independent transcriptional components by Carlos G. Urzúa-Traslaviña, Vincent C. Leeuwenburgh, Arkajyoti Bhattacharya, Stefan Loipfinger, Marcel A. T. M. van Vugt, Elisabeth G. E. de Vries, Rudolf S. N. Fehrmann

Get full text

Lessons learnt from scoring adjuvant colon cancer trials and meta-analyses using the ESMO-Magnitude of Clinical Benefit Scale V.1.1 by Elisabeth G E de Vries, Jean-Yves Douillard, Nathan I Cherny, Urania Dafni, Nicola Jane Latino, Panagiota Zygoura, Daan Geert Knapen, Derk Jan de Groot

Get full text

Modeling of Cisplatin-Induced Signaling Dynamics in Triple-Negative Breast Cancer Cells Reveals Mediators of Sensitivity by Anne Margriet Heijink, Marieke Everts, Megan E. Honeywell, Ryan Richards, Yannick P. Kok, Elisabeth G.E. de Vries, Michael J. Lee, Marcel A.T.M. van Vugt

Get full text

Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative 18F-FDG PET/CT analysis by Ellen C. de Heer, Adrienne H. Brouwers, Ronald Boellaard, Wim J. Sluiter, Gilles F. H. Diercks, Geke A. P. Hospers, Elisabeth G. E. de Vries, Mathilde Jalving

Get full text

A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions... by Agnes Jager, Elisabeth G. E. de Vries, C. Willemien Menke-van der Houven van Oordt, Patrick Neven, Clasina M. Venema, Andor W. J. M. Glaudemans, Yamei Wang, Rebecca G. Bagley, Maureen G. Conlan, Philippe Aftimos

Get full text

In-Trastuzumab Scintigraphy in HER2-Positive Metastatic Breast Cancer Patients Remains Feasible during Trastuzumab Treatment by Sietske B.M. Gaykema, Johan R. de Jong, Patrick J. Perik, Adrienne H. Brouwers, Carolien P. Schröder, Thijs H. Oude Munnink, Alphons H.H. Bongaerts, Elisabeth G.E. de Vries, Marjolijn N. Lub-de Hooge

Get full text

Phase II study (KAMELEON) of single‐agent T‐DM1 in patients with HER2‐positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinoma by Elisabeth G. E. deVries, Josef Rüschoff, Martijn Lolkema, Josep Tabernero, Luca Gianni, Emile Voest, Derk Jan A. deGroot, Daniel Castellano, Gilles Erb, Julia Naab, Margarita Donica, Regula Deurloo, Michiel S. van derHeijden, Giuseppe Viale

Get full text

Analyzing the Estrogen Receptor Status of Liver Metastases with [¹⁸F]-FES-PET in Patients with Breast Cancer by Jorianne Boers, Naila Loudini, Robbert J. de Haas, Antoon T. M. Willemsen, Bert van der Vegt, Elisabeth G. E. de Vries, Geke A. P. Hospers, Carolina P. Schröder, Andor W. J. M. Glaudemans, Erik F. J. de Vries

Get full text

HIF-1α overexpression in ductal carcinoma in situ of the breast in BRCA1 and BRCA2 mutation carriers. by Petra van der Groep, Paul J van Diest, Yvonne H C M Smolders, Margreet G E M Ausems, Rob B van der Luijt, Fred H Menko, Joost Bart, Elisabeth G E de Vries, Elsken van der Wall

Get full text

CXCR4 Inhibition with AMD3100 Sensitizes Prostate Cancer to Docetaxel Chemotherapy by Urszula M. Domanska, Hetty Timmer-Bosscha, Wouter B. Nagengast, Thijs H. Oude Munnink, Roeliene C. Kruizinga, Hildo J.K. Ananias, Nathalie M. Kliphuis, Gerwin Huls, Elisabeth G.E. De Vries, Igle J. de Jong, Annemiek M.E. Walenkamp

Get full text